Skip to main content
. 2022 Jan 27;6:e2100418. doi: 10.1200/PO.21.00418

FIG 3.

FIG 3.

Larotrectinib treatment duration. A swimmer plot of the duration of larotrectinib treatment is shown for all 20 patients whose lung cancers harbored a TRK fusion. aTwo patients had CNS metastases included as target lesions with a 100% and 59% reduction observed by cycle 4, respectively. bPatient discontinued for reasons other than progression. Each patient number refers to the same patient across all tables and figures. TRK, tropomyosin receptor kinase.